At the Forefront of Hepatology
Chicago, IL US
May 4, 2019
This educational program will increase knowledge and understanding of new technology and treatment strategies in liver disease. It will increase learner knowledge with a direct positive impact on patient outcomes.
This activity is designed for physicians and other healthcare professionals dedicated to the diagnosis and management of liver diseases.
At the conclusion of this activity, participants will be able to:
- Discuss how to implement up-to-date evidence-based medicine in the diagnosis and treatment of liver diseases;
- Describe the role of emerging technologies for medical and surgical management of liver diseases;
- Analyze treatment strategies for hepatocellular carcinoma;
- Summarize the diagnosis and treatment options for different types of hepatitis;
- Assess new and emerging therapies for different types of liver disease;
- Identify how to apply new knowledge to challenging cases in hepatology.
University of Chicago Gleacher Center
450 N Cityfront Plaza Dr.Room 100
Chicago, IL 60611
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.